EHA 2020: Advances in treatment of high-risk chronic lymphocytic leukaemia
Prognosis in high risk Chronic Lymphocytic Leukemia (CLL) is still unsatisfactory. Despite the availability of…
Browsing: chronic lymphocytic leukemia
Study reports ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia (CLL), have been shown…
CAR T-cell therapy for leukaemia leads to remissions in clinical trial
Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common…
Immune system genes linked to most common type of leukaemia
People who inherit genetic variants affecting the function of their immune system are at increased…
Australian approval for drug that ‘melts’ leukaemia
A new anti-cancer drug with the power to ‘melt away’ certain advanced forms of chronic…
Penn researchers report long-term remissions in first personalised cell therapy CLL trial
Eight of 14 patients in the first trial of the University of Pennsylvania’s personalised cellular…